The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%
Other options include hydroxychloroquine, sulfasalazine, and leflunomide
Addressing metabolism, sleep, nutrition, and psychiatric treatment together
Make every bite count with the Dietary Guidelines for Americans
If you are experiencing rapid or unexplained weight loss while on Repatha, it's imperative that you speak with your doctor
Taking your injection at night does not guarantee you will avoid side effects, but it may help you sleep through the initial peak of nausea or fatigue